Eribulin: A Novel Cytotoxic Chemotherapy Agent (June). Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, May 24, 2012

Eribulin: A Novel Cytotoxic Chemotherapy Agent (June).



Eribulin: A Novel Cytotoxic Chemotherapy Agent (June)

Ann Pharmacother. 2012 May 22;

Abstract
OBJECTIVE:To review the chemistry, pharmacology, pharmacokinetics, safety, and efficacy of eribulin (Halaven).

....Eribulin has also shown activity in Phase 2 studies in other types of cancers, such as non-small cell lung cancer, prostate cancer, urothelial cancer, soft tissue sarcomas, and platinum-susceptible ovarian, fallopian tube, or peritoneal cancers........

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.